vs
Side-by-side financial comparison of DaVita (DVA) and Molina Healthcare (MOH). Click either name above to swap in a different company.
Molina Healthcare is the larger business by last-quarter revenue ($10.8B vs $3.6B, roughly 3.0× DaVita). DaVita runs the higher net margin — 6.5% vs 0.1%, a 6.3% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs -3.1%). Over the past eight quarters, DaVita's revenue compounded faster (6.6% CAGR vs 4.5%).
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Molina Healthcare, Inc. is a managed care company headquartered in Long Beach, California, United States. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
DVA vs MOH — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.6B | $10.8B |
| Net Profit | $234.2M | $14.0M |
| Gross Margin | — | — |
| Operating Margin | 15.5% | 0.8% |
| Net Margin | 6.5% | 0.1% |
| Revenue YoY | 12.3% | -3.1% |
| Net Profit YoY | 43.8% | -64.0% |
| EPS (diluted) | $3.22 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.6B | $10.8B | ||
| Q4 25 | $3.6B | $11.4B | ||
| Q3 25 | $3.4B | $11.5B | ||
| Q2 25 | $3.4B | $11.4B | ||
| Q1 25 | $3.2B | $11.1B | ||
| Q4 24 | $3.3B | $10.5B | ||
| Q3 24 | $3.3B | $10.3B | ||
| Q2 24 | $3.2B | $9.9B |
| Q1 26 | $234.2M | $14.0M | ||
| Q4 25 | $234.2M | $-160.0M | ||
| Q3 25 | $150.3M | $79.0M | ||
| Q2 25 | $199.3M | $255.0M | ||
| Q1 25 | $162.9M | $298.0M | ||
| Q4 24 | $259.3M | $251.0M | ||
| Q3 24 | $214.7M | $326.0M | ||
| Q2 24 | $222.7M | $301.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 12.5% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 15.0% | ||
| Q4 24 | — | 14.2% | ||
| Q3 24 | — | 16.4% | ||
| Q2 24 | — | 15.3% |
| Q1 26 | 15.5% | 0.8% | ||
| Q4 25 | 15.5% | -1.4% | ||
| Q3 25 | 14.8% | 1.2% | ||
| Q2 25 | 15.9% | 3.3% | ||
| Q1 25 | 13.6% | 3.9% | ||
| Q4 24 | 17.2% | 3.6% | ||
| Q3 24 | 16.4% | 4.5% | ||
| Q2 24 | 15.9% | 4.4% |
| Q1 26 | 6.5% | 0.1% | ||
| Q4 25 | 6.5% | -1.4% | ||
| Q3 25 | 4.4% | 0.7% | ||
| Q2 25 | 5.9% | 2.2% | ||
| Q1 25 | 5.1% | 2.7% | ||
| Q4 24 | 7.9% | 2.4% | ||
| Q3 24 | 6.6% | 3.2% | ||
| Q2 24 | 7.0% | 3.0% |
| Q1 26 | $3.22 | $0.27 | ||
| Q4 25 | $3.22 | $-2.79 | ||
| Q3 25 | $2.04 | $1.51 | ||
| Q2 25 | $2.58 | $4.75 | ||
| Q1 25 | $2.00 | $5.45 | ||
| Q4 24 | $3.08 | $4.43 | ||
| Q3 24 | $2.50 | $5.65 | ||
| Q2 24 | $2.50 | $5.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $700.7M | $5.3B |
| Total DebtLower is stronger | $10.2B | $3.8B |
| Stockholders' EquityBook value | $-651.1M | $4.1B |
| Total Assets | $17.5B | $16.4B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $700.7M | $5.3B | ||
| Q4 25 | $700.7M | $8.3B | ||
| Q3 25 | $736.5M | $8.4B | ||
| Q2 25 | $739.4M | $8.8B | ||
| Q1 25 | $511.9M | $9.3B | ||
| Q4 24 | $846.0M | $9.0B | ||
| Q3 24 | $1.1B | $9.2B | ||
| Q2 24 | $437.2M | $8.7B |
| Q1 26 | $10.2B | $3.8B | ||
| Q4 25 | $10.2B | — | ||
| Q3 25 | $10.2B | — | ||
| Q2 25 | $10.1B | — | ||
| Q1 25 | $9.6B | — | ||
| Q4 24 | $9.2B | — | ||
| Q3 24 | $9.3B | — | ||
| Q2 24 | $8.5B | — |
| Q1 26 | $-651.1M | $4.1B | ||
| Q4 25 | $-651.1M | $4.1B | ||
| Q3 25 | $-571.9M | $4.2B | ||
| Q2 25 | $-369.6M | $4.6B | ||
| Q1 25 | $-267.1M | $4.3B | ||
| Q4 24 | $121.1M | $4.5B | ||
| Q3 24 | $386.7M | $4.8B | ||
| Q2 24 | $632.9M | $4.8B |
| Q1 26 | $17.5B | $16.4B | ||
| Q4 25 | $17.5B | $15.6B | ||
| Q3 25 | $17.6B | $15.7B | ||
| Q2 25 | $17.5B | $16.2B | ||
| Q1 25 | $17.1B | $16.4B | ||
| Q4 24 | $17.3B | $15.6B | ||
| Q3 24 | $17.5B | $15.8B | ||
| Q2 24 | $17.0B | $15.2B |
| Q1 26 | — | 0.92× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 75.76× | — | ||
| Q3 24 | 23.95× | — | ||
| Q2 24 | 13.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.1B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 77.29× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $540.7M | $-298.0M | ||
| Q3 25 | $841.5M | $-125.0M | ||
| Q2 25 | $324.2M | $-302.0M | ||
| Q1 25 | $180.0M | $190.0M | ||
| Q4 24 | $547.6M | $-224.0M | ||
| Q3 24 | $810.4M | $873.0M | ||
| Q2 24 | $798.8M | $-219.0M |
| Q1 26 | — | — | ||
| Q4 25 | $395.3M | $-299.0M | ||
| Q3 25 | $675.4M | $-163.0M | ||
| Q2 25 | $203.1M | $-344.0M | ||
| Q1 25 | $36.8M | $168.0M | ||
| Q4 24 | $377.0M | $-235.0M | ||
| Q3 24 | $671.4M | $838.0M | ||
| Q2 24 | $674.1M | $-246.0M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | -2.6% | ||
| Q3 25 | 19.7% | -1.4% | ||
| Q2 25 | 6.0% | -3.0% | ||
| Q1 25 | 1.1% | 1.5% | ||
| Q4 24 | 11.4% | -2.2% | ||
| Q3 24 | 20.6% | 8.1% | ||
| Q2 24 | 21.2% | -2.5% |
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | 0.0% | ||
| Q3 25 | 4.9% | 0.3% | ||
| Q2 25 | 3.6% | 0.4% | ||
| Q1 25 | 4.4% | 0.2% | ||
| Q4 24 | 5.2% | 0.1% | ||
| Q3 24 | 4.3% | 0.3% | ||
| Q2 24 | 3.9% | 0.3% |
| Q1 26 | — | 77.29× | ||
| Q4 25 | 2.31× | — | ||
| Q3 25 | 5.60× | -1.58× | ||
| Q2 25 | 1.63× | -1.18× | ||
| Q1 25 | 1.10× | 0.64× | ||
| Q4 24 | 2.11× | -0.89× | ||
| Q3 24 | 3.77× | 2.68× | ||
| Q2 24 | 3.59× | -0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVA
Segment breakdown not available.
MOH
| Premium revenue | $10.2B | 94% |
| Premium tax revenue | $504.0M | 5% |
| Investment income | $98.0M | 1% |
| Other revenue | $22.0M | 0% |
